⚲
|
Haemonetics Corp | |
---|---|
Ticker | HAE |
CIK # | 0000313143 |
CUSIP | 405024100 |
Sector | Life Sciences |
Industry | Surgical & Medical Instruments & Apparatus |
Phone | 7818487100 |
Address | 400 Wood Rd Braintree, MA 02184 |
Source | [EDGAR] |
Market Cap, 13F ($) |
---|
Business |
---|
Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions to customers to help improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets including blood and plasma component collection, the surgical suite, and hospital transfusion services. When used in this report, the terms "we," "us," "our" and "the Company" mean Haemonetics. Blood is essential to a modern healthcare system. Blood and its components (plasma, platelets and red cells) have many vital and frequently life-saving clinical applications. Plasma is used for patients with major blood loss and is manufactured into biopharmaceuticals to treat a variety of illnesses, including immune diseases and coagulation disorders. Red cells treat trauma patients or patients undergoing surgery with high blood loss, such as open heart surgery or organ transplant. Platelets have many uses in patient care, including supporting cancer patients undergoing chemotherapy. Haemonetics develops and markets a wide range of devices and solutions to serve our customers. Our Plasma business unit provides plasma collection devices and disposables and plasma donor management software that enable the collection of plasma used by biopharmaceutical companies to make life saving pharmaceuticals. Our Blood Center business unit offers blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management |
CIK | Filing | 2011 - 2023 |
---|---|---|
[0000313143] | 10-K | |
[0000313143] | 10-Q | |
[0000313143] | 3 | |
[0000313143] | 4 | |
[0000313143] | 5 | |
[0000313143] | 8-K | |
[0000313143] | SC 13G |